Association of factor VIII and factor IX mutations, HLA Class II, tumour necrosis factor-α and interleukin-10 on inhibitor development among Thai haemophilia A and B patients.
作者信息
Chuansumrit A, Sasanakul W, Sirachainan N, Kadegasem P, Wongwerawattanakoon P, Mahaklan L, Nathalang O
机构信息
Department of Pediatrics, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.
Department of Nursing, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.
出版信息
Haemophilia. 2017 Nov;23(6):e518-e523. doi: 10.1111/hae.13344. Epub 2017 Sep 11.
PMID:28891589
Abstract
摘要
相似文献
1
Association of factor VIII and factor IX mutations, HLA Class II, tumour necrosis factor-α and interleukin-10 on inhibitor development among Thai haemophilia A and B patients.泰国甲型和乙型血友病患者中因子VIII和因子IX突变、HLA II类、肿瘤坏死因子-α及白细胞介素-10与抑制剂形成的关联
Haemophilia. 2017 Nov;23(6):e518-e523. doi: 10.1111/hae.13344. Epub 2017 Sep 11.
2
F8 and F9 mutations in US haemophilia patients: correlation with history of inhibitor and race/ethnicity.美国血友病患者 F8 和 F9 突变：与抑制剂史和种族/民族的相关性。
Haemophilia. 2012 May;18(3):375-82. doi: 10.1111/j.1365-2516.2011.02700.x. Epub 2011 Nov 21.
3
A genetic view on the etiology of the inhibitor complication.关于抑制剂并发症病因的遗传学观点。
Blood. 1996 Mar 15;87(6):2612.
4
Key issues in inhibitor management in patients with haemophilia.血友病患者抑制剂管理中的关键问题。
Blood Transfus. 2014 Jan;12 Suppl 1(Suppl 1):s319-29. doi: 10.2450/2013.0246-12. Epub 2013 Dec 3.
5
A study of prospective surveillance for inhibitors among persons with haemophilia in the United States.美国血友病患者前瞻性抑制物监测研究。
Haemophilia. 2014 Mar;20(2):230-7. doi: 10.1111/hae.12302. Epub 2013 Nov 22.
6
[DNA analysis in the inhibitor phenotype of the hemophilias].[血友病抑制物表型中的DNA分析]
Rinsho Ketsueki. 1993 May;34(5):578-82.
7
Diagnosis and treatment of factor VIII and IX inhibitors in congenital haemophilia: (4th edition). UK Haemophilia Centre Doctors Organization.先天性血友病中因子 VIII 和 IX 抑制剂的诊断与治疗：（第4版）。英国血友病中心医生组织。
Br J Haematol. 2013 Jan;160(2):153-70. doi: 10.1111/bjh.12091. Epub 2012 Nov 15.
8
The multifactorial etiology of inhibitor development in hemophilia: genetics and environment.血友病抑制剂产生的多因素病因：遗传与环境。
Semin Thromb Hemost. 2009 Nov;35(8):723-34. doi: 10.1055/s-0029-1245105. Epub 2010 Feb 18.
9
Comparative study of the prevalence of clotting factor deficiency in carriers of haemophilia A and haemophilia B.甲型血友病和乙型血友病携带者凝血因子缺乏患病率的比较研究。
Haemophilia. 2017 Sep;23(5):e471-e473. doi: 10.1111/hae.13298. Epub 2017 Jul 9.
10
The molecular basis of haemophilia A and B.
Baillieres Clin Haematol. 1996 Jun;9(2):211-28. doi: 10.1016/s0950-3536(96)80059-x.
Zotero 插件